The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Arimidex Observational: Reason for and Effect of Change From Tamoxifen
Official Title: Arimidex: Reason for and Effect of Change From Tamoxifen
Study ID: NCT00246961
Brief Summary: The purpose of this study is to analyse the effect on quality of life after 3 months of treatment after changing adjuvant therapy from tamoxifen to Arimidex.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Research Site, 'S-Gravenhage, , Netherlands
Research Site, 's-Hertogenbosch, , Netherlands
Research Site, Alkmaar, , Netherlands
Research Site, Antwerpen, , Netherlands
Research Site, Apeldoorn, , Netherlands
Research Site, Bergen op Zoom, , Netherlands
Research Site, Boxmeer, , Netherlands
Research Site, Breda, , Netherlands
Research Site, Doetinchem, , Netherlands
Research SIte, Dordrecht, , Netherlands
Research Site, Ede, , Netherlands
Research Site, Eindhoven, , Netherlands
Research Site, Enschede, , Netherlands
Research Site, Geldrop, , Netherlands
Research Site, Groningen, , Netherlands
Research Site, Harderwijk, , Netherlands
Research Site, Helmond, , Netherlands
Research Site, Hoogeveen, , Netherlands
Research Site, Hoorn, , Netherlands
Research Site, Leiden, , Netherlands
Research Site, Oosterhout, , Netherlands
Research Site, Purmerend, , Netherlands
Research Site, Roermond, , Netherlands
Research Site, Roosendaal, , Netherlands
Research Site, Rotterdam, , Netherlands
Research Site, Schiedam, , Netherlands
Research Site, Terneuzen, , Netherlands
Research Site, Tiel, , Netherlands
Research Site, Venray, , Netherlands
Research Site, Vlissingen, , Netherlands
Research Site, Winterswijk, , Netherlands
Research Site, Zoetermeer, , Netherlands
Research Site, Zutphen, , Netherlands
Name: AstraZeneca The Netherlands Medical Director, MD
Affiliation: AstraZeneca
Role: STUDY_DIRECTOR